Skip to search formSkip to main contentSkip to account menu

liraglutide Pen Injector [Saxenda]

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
  • Sungrae Kim
  • The Journal of Korean Diabetes
  • 2019
  • Corpus ID: 199038188
Corresponding author: Sungrae Kim Division of Endocrine and Metabolism, The Catholic University of Korea, Bucheon St. Mary’s… 
Review
2017
Review
2017
2016
2016
Obesity is a significant concern in the United States, affecting approximately 35% of the population. Comorbidities, such as… 
2016
2016
Obesity is a significant concern in the United States, affecting approximately 35% of the population. Comorbidities, such as… 
Review
2015
Review
2015
Globally, obesity has reached epidemic proportions and poses an ever increasing burden from a societal and healthpayer… 
2015
2015
Liraglutide (Saxenda®; 3 mg dose), a glucagon-like peptide-1 receptor agonist, is indicated as an adjunct to a reduced-calorie… 
2015
2015
Despite much advertising to the contrary, there are no dietary supplements that safely and effectively cause weight loss… 
Review
2015
Review
2015
This article highlights important prescribing information for some drugs that received FDA approval within the past year. These…